Recent Quarter Total Invested
$402.04 M
Recent Quarter Institutional Ownership Percentage
104.56%
Total Invested of Last Quarter
$569.71 M
Ownership Percentage of Last Quarter
98.48%
Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 11.61 M | $71.98 M | 0.00% | 18.73% |
| RTW INVESTMENTS, LP | 08/14/2024 | 5.85 M | $36.24 M | 0.00% | 9.43% |
| FMR LLC | 08/13/2024 | 5.33 M | $33.05 M | -0.65% | 8.60% |
| BLACKROCK INC. | 08/13/2024 | 4.80 M | $29.75 M | 211.35% | 7.74% |
| VANGUARD GROUP INC | 08/13/2024 | 3.07 M | $19.04 M | 20.97% | 4.95% |
| COWEN AND COMPANY, LLC | 08/07/2024 | 2.96 M | $18.38 M | -20.19% | 4.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 2.54 M | $15.75 M | -10.79% | 4.10% |
| TRV GP IV, LLC | 08/09/2024 | 2.34 M | $14.53 M | 0.00% | 3.78% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 2.08 M | $12.93 M | 51.23% | 3.36% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.78 M | $11.02 M | 34.08% | 2.87% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 1.50 M | $9.30 M | 50.00% | 2.42% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 1.48 M | $9.18 M | 13.50% | 2.39% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 1.44 M | $8.96 M | 27.06% | 2.33% |
| JEFFERIES FINANCIAL GROUP INC. | 08/13/2024 | 1.43 M | $8.89 M | 24.45% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.31 M | $8.11 M | 132.03% | 2.11% |
| MORGAN STANLEY | 10/17/2024 | 1.23 M | $7.66 M | 6.71% | 1.99% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 1.16 M | $7.19 M | 66.91% | 1.87% |
| STATE STREET CORP | 08/14/2024 | 1.04 M | $6.46 M | 305.38% | 1.68% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 849,193 | $5.26 M | 3.17% | 1.37% |
| PROPEL BIO MANAGEMENT, LLC | 08/12/2024 | 750,000 | $4.65 M | 0.00% | 1.21% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 727,673 | $4.51 M | 0.00% | 1.17% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 696,464 | $4.32 M | 71.08% | 1.12% |
| SIMPLIFY ASSET MANAGEMENT INC. | 08/12/2024 | 674,832 | $4.18 M | -0.18% | 1.09% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 591,785 | $3.67 M | -5.34% | 0.95% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 563,500 | $3.49 M | 34.10% | 0.91% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 560,492 | $3.48 M | -30.83% | 0.90% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 553,307 | $3.43 M | -23.49% | 0.89% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 525,300 | $3.26 M | 66.52% | 0.85% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 509,688 | $3.16 M | 190.88% | 0.82% |
| WOODLINE PARTNERS LP | 08/14/2024 | 501,301 | $3.11 M | 100.00% | 0.81% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 497,456 | $3.08 M | 100.00% | 0.80% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 402,749 | $2.50 M | -55.12% | 0.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 398,436 | $2.47 M | 0.00% | 0.64% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 368,369 | $2.28 M | 8.40% | 0.59% |
| MARSHALL WACE, LLP | 08/14/2024 | 333,161 | $2.07 M | 47.70% | 0.54% |
| EXOME ASSET MANAGEMENT LLC | 10/03/2024 | 302,700 | $1.88 M | 100.00% | 0.49% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 300,000 | $1.86 M | -72.89% | 0.48% |
| BESSEMER GROUP INC | 08/13/2024 | 286,988 | $1.78 M | 0.00% | 0.46% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 285,000 | $1.77 M | 119.23% | 0.46% |
| ABRDN PLC | 08/09/2024 | 256,888 | $1.59 M | 0.00% | 0.41% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 250,000 | $1.55 M | -9.09% | 0.40% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 222,982 | $1.38 M | 19.26% | 0.36% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 210,000 | $1.30 M | 100.96% | 0.34% |
| MASS GENERAL BRIGHAM, INC | 07/31/2024 | 205,356 | $1.27 M | 0.00% | 0.33% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 202,148 | $1.25 M | 0.00% | 0.33% |
| UBS GROUP AG | 08/14/2024 | 190,551 | $1.18 M | 161.86% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 186,727 | $1.16 M | 100.00% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 182,729 | $1.13 M | 5.83% | 0.29% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 175,983 | $1.09 M | 618.74% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 169,549 | $1.05 M | 100.00% | 0.27% |
Fulcrum Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of FULC shares?
During the previous two years, 81 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:
abrdn plc: 0
AIGEN INVESTMENT MANAGEMENT, LP: 0
Alpine Global Management, LLC: 0
Alyeska Investment Group, L.P.: 0
Aquatic Capital Management LLC: 0
BANK OF MONTREAL /CAN/: 0
-
What percentage of Fulcrum Therapeutics, Inc. stock is owned by institutional investors?
104.56% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at FULC ?
Institutional investors have bought a total of 16.38 M shares in the last 24 months. This purchase volume represents approximately $49.80 M in transactions.